New warning for Champix

Published: 2008-02-14 06:58:00

Updated: 2008-02-14 06:58:00

The Korea Food and Drug Administration said it has called for increased awareness of the health risks of the smoking cessation drug Champix (varenicline).

To that end, the administration has requested Pfizer Korea, the manufacturer of Champix, to revise the summary of product characteristics i...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK